Protalix BioTherapeutics
PLX
PLX
28 hedge funds and large institutions have $15.5M invested in Protalix BioTherapeutics in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $36K
Holders
28
Holding in Top 10
–
Calls
$1K
Puts
$36K
Top Buyers
| 1 | +$30.8K | |
| 2 | +$7K | |
| 3 | +$2.73K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$593 |
Top Sellers
| 1 | -$871K | |
| 2 | -$90K | |
| 3 | -$41.5K | |
| 4 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$40.1K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$30.1K |